Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer

Authors

Lindsay M. Kuroki, Washington University School of Medicine in St. Louis
Xingjian Jin, Washington University School of Medicine in St. Louis
Igor P. Dmitriev, Washington University School of Medicine in St. Louis
Elena A. Kashentseva, Washington University School of Medicine in St. Louis
Matthew A. Powell, Washington University School of Medicine in St. Louis
David G. Mutch, Washington University School of Medicine in St. Louis
Allan B. Dietz, Mayo Clinic, Rochester
David T. Curiel, Washington University School of Medicine in St. Louis
William G. Hawkins, Washington University School of Medicine in St. Louis
Dirk Spitzer, Washington University School of Medicine in St. Louis

Journal

PLoS One

Publication Date

2017

Volume

12

Issue

12

Inclusive Pages

e0190125

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0190125

Rights and Permissions

Kuroki LM, Jin X, Dmitriev IP, Kashentseva EA, Powell MA, et al. (2017) Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer. PLOS ONE 12(12): e0190125. https://doi.org/10.1371/journal.pone.0190125

Recommended Citation

Kuroki, Lindsay M.; Jin, Xingjian; Dmitriev, Igor P.; Kashentseva, Elena A.; Powell, Matthew A.; Mutch, David G.; Dietz, Allan B.; Curiel, David T.; Hawkins, William G.; and Spitzer, Dirk, "Adenovirus platform enhances transduction efficiency of human mesenchymal stem cells: An opportunity for cellular carriers of targeted TRAIL-based TR3 biologics in ovarian cancer." PLoS One. 12, 12. e0190125. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6455